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1.1 Pharmacokinetic Profiles
The variations of concentration and exposure (integral of concentration with respect to time)
in time are shown for each of the three pharmacokinetic supply profiles described in Section
3 of the main manuscript, in Figures 1 and 2, respectively. We acknowledge that profile PK3
is not physiologic, but instead represents a prolonged exposure at constant concentration.
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Figure 1: Comparison of concentration profiles, Cv(t), for the three input PK profiles described
in Section 3 of the main manuscript. The right-hand plot shows a magnification of the bottom
left corner of the left-hand plot.
1.2 Two-Dimensional Profiles
The variations of concentration and exposure (integral of concentration with respect to time)
in time are shown at points in the tissue close to and far from the source, for each of the
three pharmacokinetic profiles described in Section 3 of the main manuscript, in Figures 3
(free extracellular drug, C1) and 4 (bound intracellular drug, C3).
• Close to the supply, the concentration and exposure profiles of the free extracellular
drug (C1) are very similar to those of the supplied PK profiles, Cv(t), shown in Figures
1 and 2. At greater distances from the supply the shapes of the curves remain similar
but the concentrations are lower.
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Figure 2: Comparison of exposure profiles, (
∫ t
0
Cv(τ) dτ), for the three input PK profiles de-
scribed in Section 3 of the main manuscript.
• The bound intracellular drug profiles also have similarities, but they are much smoother.
They take longer to reach peak concentrations and the decay from those concentrations
is much slower. This is exaggerated further away from the supply.
Figure 5 illustrates one potential consequence of changing the supplied pharmacokinetic
profile. A threshold is assigned and, if the exposure to bound intracellular drug within
a computational compartment exceeds this value, the cells are assumed to die, otherwise
they remain alive, as described in the remark at the end of Section 4.3. For the specified
parameters (here chosen to represent narrow, leaky, vessels) and this threshold value, the
uniform profile representing prolonged exposure at constant concentration, PK3, given by
Equation (14) in Section 3 of the main manuscript, kills the most cells (shown on the right
of the figure), while the profile representing three short infusions, PK2, given by Equation
(13) in Section 3 of the main manuscript, kills the least (shown in the middle of the figure).
1.3 Spherically-Symmetric Compartment Model (1D)
In [1] the binding model was augmented with a spatial component by exploiting the shell-like
nature of tumour cords, the geometric property that cells are broadly arranged in concen-
tric circles around a central blood vessel. Here we consider a different geometry, made up of
concentric spherical shells with no central vessel and drug being supplied at the outer bound-
ary. This models an avascular multicell spheroid, bathed in drug. It is assumed that the
rate of transport of drug between neighbouring shells is proportional to the shared interface
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Figure 3: Dependence on time of the concentration of free extracellular drug (C1, top) and
exposure to free extracellular drug (
∫ t
0
C1(τ) dτ , bottom) at a point close to the supply of drug
(r = 26µm, z = 10µm, left) and far from it (r = 186µm, z = 490µm, right).
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Figure 4: Dependence on time of the concentration of bound intracellular drug (C3, top) and
exposure to bound intracellular drug (
∫ t
0
C3(τ) dτ , bottom) at a point close to the supply of drug
(r = 26µm, z = 10µm, left) and far from it (r = 186µm, z = 490µm, right).
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Figure 5: Thresholding of the exposure to bound drug (
∫ t
0
C3(τ) dτ) at t = 72 h: parameters
as in Table 1 of the main manuscriptexcept that kv → 10kv (higher vessel wall permeability),
λ → λ/10 (lower blood flow velocity) and l → l/2 (smaller vessel radius). Yellow (dead) cells
have exposures above 165µMh, blue (live) cells have exposures below this value.
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area (denoted by Ai+1/2 for the interface between shells i and i + 1) and the difference in
concentration across the interface.
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Figure 6: Slice through geometry for one-dimensional multicell spheroid compartment model
with spherical symmetry and drug supplied from outside. The thick black vertical line represents
the computational domain.
Under these assumptions, following the description of the one-dimensional cylindrically-
symmetric compartment model developed in [1], the spatial variation in the radial direction
can be included by augmenting Equations (1)-(3) of the main manuscript to give
δ1V
idC
i
1
dt
= Ai−1/2k0(C
i−1
1 − C i1) + Ai+1/2k0(C i+11 − C i1)
+ aik1(C
i
2 − C i1) , (1)
δ2V
idC
i
2
dt
= aik1(C
i
1 − C i2)
− δ2V ik2C i2(C0 − C i3) + δ2V ik−2C i3 , (2)
δ2V
idC
i
3
dt
= δ2V
ik2C
i
2(C0 − C i3) − δ2V ik−2C i3 , (3)
for i = 1, . . . , n, where n is the number of shells, and ai is the cellular surface area within
the ith shell. The superscript corresponds to the shell number, and this index increases with
distance from the centre of the spherical coordinates. Half-indices correspond to interfaces
between shells, as illustrated in Figure 6.
These equations are precisely the same as those of our one-dimensional, cylindrically-
symmetric, computational model (Equations (7)-(9) in [1]) – the model differs only in the
definition of the geometric quantities and the boundary conditions. At the outer bound-
ary, a predefined pharmacokinetic profile, Cv(t), is prescribed, so when i = n the term
An+1/2k0(C
n+1
1 −Cn1 ) is replaced by An+1/2k0(Cv(t)−Cn1 ) in Equation (1). A symmetry/no-
flux condition is imposed at the centre of the spheroid by replacing the term A1/2k0(C
0
1−C11 )
with zero when i = 1 in Equation (1). The volumes V i of the shells are determined from the
6
geometry: assuming a shell thickness d, the volume of the ith shell is
V i =
4
3
pid3(i3 − (i− 1)3) . (4)
The factors δ1 =
δ
1+δ
and δ2 =
1
1+δ
are defined so that δ1 V
i and δ2 V
i are, respectively, the
extracellular and intracellular volumes in the ith layer (δ being the ratio of extracellular to
intracellular volume). The interface area between shells i and i+ 1 is
Ai = 4pid2i2 . (5)
Values are given for the geometric and transport parameters in Table 1 of the main manuscript,
except that
α = ai/V i = 3/(r
3
√
1 + δ) . (6)
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